![](/img/cover-not-exists.png)
Randomized phase II non-inferiority study (NO16853) of two different doses of capecitabine in combination with docetaxel for locally advanced/metastatic breast cancer
Buzdar, A. U., Xu, B., Digumarti, R., Goedhals, L., Hu, X., Semiglazov, V., Cheporov, S., Gotovkin, E., Hoersch, S., Rittweger, K., Miles, D. W., O'Shaughnessy, J., Tjulandin, S.Volume:
23
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdr256
Date:
March, 2012
File:
PDF, 571 KB
english, 2012